Seroprevalence and Associated Factors of SARS CoV-2 Antibodies among employees of IMDC and its teaching hospital
Since the emergence of COVID-19 in Wuhan, China, it has claimed many lives and global economic losses. Healthcare workers have been the most exposed group in this pandemic. This study aims to determine the prevalence of anti-SARS-CoV-2 antibodies among the employees of Islamabad Medical and Dental College and its allied hospital Akbar Niazi Teaching Hospital.
All members of the staff and faculty of Islamabad Medical and Dental College and allied hospital Akbar Niazi Teaching Hospital were encouraged to get tested for SARS-CoV-2 antibodies and 294 employees volunteered for the study from 23rd July to 30th July,2020 through Elecsys® Anti-SARS-CoV-2 (Immunoassay for the qualitative detection of IgG antibodies against SARS-CoV-2 in human serum and plasma).
Out of 284 volunteers, 87 (30.6%) were SARS-CoV-2 antibody positive, with the mean antibody level in seropositive individuals recorded as 24.4418 ± 25.3494. , housekeeping and sanitary workers were the most affected; 14 (48.3%) were antibody positive, while 15 (51.7%) were antibody negative. After housekeeping and sanitary staff, the second most affected workers were lab technicians (37.1% were positive compared to 62.9% negative). Fever, loss of taste or smell and breathing difficulty were the most significantly associated symptoms with COVID-19 antibody seroprevalence as suggested by the p values 0.003, 0.004 and 0.032 respectively. Out of the 13 PCR positive participants (in the preceding 3 months) 10 (76.9%) showed positive antibody in their serum and 3 (23.1%) had not developed antibodies.
Seroprevalence of SARS-CoV-2 antibodies was estimated to be high among the healthcare staff (30.6%), with the housekeeping and sanitary staff to be the most affected employees, probably due to the breach of personal protection. Fever, loss of taste or smell and breathing were strongly associated with seropositivity of SARS-CoV-2 antibodies.
Key Words: SARS-CoV-2, antibody testing, Covid-19, healthcare workers
1. (OMS) WHO. COVID-19 Weekly Epidemiological Update [Internet]. 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20201012-weekly-epi-update-9.pdf
2. Xie J, Ding C, Li J, Wang Y, Guo H, Lu Z, et al. Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test. J Med Virol. 2020 Oct;92(10):2004-2010. doi: 10.1002/jmv.25930. Epub 2020 May 7. PMID: 32330303; PMCID: PMC7264659.
3. Jacofsky D, Jacofsky EM, Jacofsky M. Understanding Antibody Testing for COVID-19. J Arthroplasty. 2020 Jul;35(7S):S74-S81. doi: 10.1016/j.arth.2020.04.055. Epub 2020 Apr 27. PMID: 32389405; PMCID: PMC7184973.
4. Yan M, Zheng Y, Sun Y, Wang L, Luan L, Liu J, Tian X, Wan N. Analysis of the diagnostic value of serum specific antibody testing for coronavirus disease 2019. J Med Virol. 2020 Jun 27:10.1002/jmv.26230. doi: 10.1002/jmv.26230. Epub ahead of print. PMID: 32592502; PMCID: PMC7361814.
5. Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012. PMID: 32433946; PMCID: PMC7236739.
6. Bhopal RS. COVID-19 zugzwang: Potential public health moves towards population (herd) immunity. Public Health in Practice. 2020 Nov;1:100031. doi: 10.1016/j.puhip.2020.100031. Epub 2020 Dec 22. PMCID: PMC7361085.
7. Chen Y, Tong X, Wang J, Huang W, Yin S, Huang R, et al. High SARS-CoV-2 antibody prevalence among healthcare workers exposed to COVID-19 patients. J Infect. 2020 Sep;81(3):420-426. doi: 10.1016/j.jinf.2020.05.067. Epub 2020 Jun 4. PMID: 32504745; PMCID: PMC7270786.
8. Garcia-Basteiro AL, Moncunill G, Tortajada M, Vidal M, Guinovart C, Jiménez A, et al. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital. Nat Commun. 2020 Jul 8;11(1):3500. doi: 10.1038/s41467-020-17318-x. PMID: 32641730; PMCID: PMC7343863.
9. Jeremias A, Nguyen J, Levine J, Pollack S, Engellenner W, Thakore A, et al. Prevalence of SARS-CoV-2 infection among health care workers in a tertiary community hospital. JAMA Internal Medicine. 2020 Dec 1;180(12):1707-9. doi:10.1001/jamainternmed.2020.4214
10. Korth J, Wilde B, Dolff S, Anastasiou OE, Krawczyk A, Jahn M, et al. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients. J Clin Virol. 2020 Jul;128:104437. doi: 10.1016/j.jcv.2020.104437. Epub 2020 May 13. PMID: 32434708; PMCID: PMC7219425.
11. Fusco FM, Pisaturo M, Iodice V, Bellopede R, Tambaro O, Parrella G, et al. COVID-19 among healthcare workers in a specialist infectious diseases setting in Naples, Southern Italy: results of a cross-sectional surveillance study. J Hosp Infect. 2020 Aug;105(4):596-600. doi: 10.1016/j.jhin.2020.06.021. Epub 2020 Jun 18. PMID: 32565367; PMCID: PMC7301109.
12. Lackermair K, William F, Grzanna N, Lehmann E, Fichtner S, Kucher HB, et al. Infection with SARS-CoV-2 in primary care health care workers assessed by antibody testing. Fam Pract. 2020 Aug 7:cmaa078. doi: 10.1093/fampra/cmaa078. Epub ahead of print. PMID: 32766704; PMCID: PMC7454542.
13. Rudberg AS, Havervall S, Månberg A, Jernbom Falk A, Aguilera K, Ng H, et al. SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden. Nat Commun. 2020 Oct 8;11(1):5064. doi: 10.1038/s41467-020-18848-0. PMID: 33033249; PMCID: PMC7544689.
14. Colaneri M, Novelli V, Cutti S, Muzzi A, Resani G, Monti MC, et al. The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection. J Public Health (Oxf). 2020 Nov 3:fdaa195. doi: 10.1093/pubmed/fdaa195. Epub ahead of print. PMID: 33140084; PMCID: PMC7665642.
15. Iversen K, Bundgaard H, Hasselbalch RB, Kristensen JH, Nielsen PB, Pries-Heje M, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020 Dec;20(12):1401-1408. doi: 10.1016/S1473-3099(20)30589-2. Epub 2020 Aug 3. Erratum in: Lancet Infect Dis. 2020 Oct;20(10):e250. PMID: 32758438; PMCID: PMC7398038.
16. Kohler PP, Kahlert CR, Sumer J, Flury D, Güsewell S, Leal-Neto OB, et al. Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study. Infect Control Hosp Epidemiol. 2020 Oct 8:1-5. doi: 10.1017/ice.2020.1244. Epub ahead of print. PMID: 33028454; PMCID: PMC7582018.
17. Wajnberg A, Mansour M, Leven E, Bouvier NM, Patel G, Firpo-Betancourt A, et al. Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study. The Lancet Microbe. 2020 Nov 1;1(7):e283-9.
Copyright (c) 2021 Farah Rashid, Sadia Zafar, Usman Zafar, Nadia Tariq, Khalid Hassan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
All research articles published in the Journal of Rawalpindi Medical College (JRMC) are fully open access: immediately freely available to read, download, and share. Copyrights of all articles published in JRMC are retained by the authors. First publication rights are granted to JRMC. The journal/publisher is not responsible for subsequent uses of the work.
All articles are published under the Creative Commons Attribution (CC BY-SA 4.0) license.